Skip to content

CARMINE AMICONE

Active
Private limited companyfounded 2025active for 1 yearRue Visé-Voie 23, 4680 Oupeye, BelgiumKBO/BCE: BE 1023.052.367

From the official registers: KBO 1 annual account at the National Bank publications in the Belgian Official Gazette

Summary

CARMINE AMICONE has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €12,752 and a net result of €10,252. Its solvency ranks better than 19% of 20,659 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

KBO
Status
Active since 06-05-2025 Normal situation
Legal form
Private limited company
Registered office
Rue Visé-Voie 23, 4680 Oupeye
Activity
Physiotherapy NACE 86951
Establishment unit
2.373.761.036 4680 Oupeye, since 06-05-2025
Financial year end
31 December
Peppol
Reachable since 06-12-2025

Who decides

Board

How it is doing

90 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€18,635
Turnover
≈ €120,000
estimated
Profit
€10,252
Equity
€12,752
Total assets
€68,234
2025 accounts filed 26 days late
Filed on 26-08-2026at the National Bank
Why 90raises riskFounded in 2025Liquidity: current ratio 0.22, cash €4,153lowers riskSector: Human health activities (NACE 86)Figures for financial year 2025 (filed 26-08-2026)Show the evidence

Checked score

Score 2025
90 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 20% of its sector peers (NACE 86, micro)
Financial strength
Average
Solvency 44
equity 18.7% of total assets
Liquidity 13
short-term debt 81.3% · cash 6.1%
Profitability 88
return on assets 15.0%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 06-2026: 0.3% 07-2026: 0.3%● unchanged vs 06-2026highest value 08-2026: 0.3%● unchanged vs 07-2026highest value 09-2026: 0.1%▼ -0.2 percentage points vs 08-2026lowest value 10-2026: 0.1%● unchanged vs 09-2026
Credit of up to €1,000 on 30-day terms is acceptable
Liquidity insufficient (current ratio 0.22, below 1; short-term debt: 81.3% and cash: 6.1% of total assets), and 81.3% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 19% on solvency, 2% on liquidity and 40% on profitability.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Founded in 2025
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Figures for financial year 2025 (filed 26-08-2026)
NBB · annual accounts
raises risk · Liquidity: current ratio 0.22, cash €4,153
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 19% of 20659 sector peers (2025).
NBB · sector comparison
Position among 20659 sector peers
Solvency
better than 19%
← weakest strongest →
raises risk · 2025 accounts filed 26 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-08-2026, 26 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 1 filing
Deviation from the deadline
2025
26 days late
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2025.
KBO publications · our coverage

Key points

  • Caution: Among the weakest 14% on equitysector median €124,506 · 20,661 companies €12,752 View

Documents

Annual accounts at the NBB

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about CARMINE AMICONE

What is the company number of CARMINE AMICONE?
1023.052.367. In Belgium the VAT number is the company number with BE in front: BE 1023.052.367.
Where is CARMINE AMICONE based?
The registered office is at Rue Visé-Voie 23, 4680 Oupeye.Company details
What does CARMINE AMICONE do?
According to the KBO register, the main activity is physiotherapy (NACE 86951).
What is the legal form of CARMINE AMICONE?
Private limited company (BV).
When was CARMINE AMICONE founded?
On 06-05-2025.
Is CARMINE AMICONE still active?
Yes, CARMINE AMICONE is an active enterprise in the KBO register.
What is the turnover of CARMINE AMICONE?
≈ €120,000 in financial year 2025. Estimated from the gross margin of €18,635: probably between €75,000 and €210,000, based on 41 comparable companies, NACE 869. A rough estimate.Financials
Is CARMINE AMICONE profitable?
In financial year 2025, CARMINE AMICONE made a profit of €10,252.
Where can I find the annual accounts of CARMINE AMICONE?
CARMINE AMICONE filed 1 annual account with the National Bank of Belgium, for financial year 2025.Annual accounts at the National Bank

Companies related to CARMINE AMICONE

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.